GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **876 - 900** of **4050** in total

« First

‹ Prev

…

32

33

34

35

36

37

38

39

40

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID	Arbitrary Fluorescence Units (AFU) ▲
IgM	Patient 1	6	moderate	G75896PD	52
IgM	Patient 1	6	moderate	G90223GH	52
IgG	Patient 2	24	mild	G29011JC	52
IgG	Patient 2	3	mild	G17390SF	52
IgG	Patient 2	3	mild	G89993FE	52
IgG	Patient 3	-180	mild	G29857RC	52
IgG	Patient 3	-180	mild	G78074HX	52
IgG	Patient 3	11	mild	G00052MO	52
IgM	Patient 3	-180	mild	G15209MJ	52
IgM	Patient 3	-180	mild	G86156UJ	52
IgG	Patient 3	4	mild	G00052MO	52
IgG	Patient 4	12	mild	G27689OB	52
IgG	Patient 1	10	moderate	G21290RB	53
IgG	Patient 1	10	moderate	G68461PT	53
IgM	Patient 1	10	moderate	G27689OB	53
IgM	Patient 1	10	moderate	G71469XA	53
IgM	Patient 1	22	moderate	G43648DB	53
IgM	Patient 1	22	moderate	G68703KI	53
IgG	Patient 1	6	moderate	G96865DJ	53
IgM	Patient 1	6	moderate	G19868AX	53
IgM	Patient 1	6	moderate	G27689OB	53
IgM	Patient 1	6	moderate	G53168IY	53
IgM	Patient 1	6	moderate	G96865DJ	53
IgG	Patient 2	3	mild	G58547FH	53
IgG	Patient 2	3	mild	G61751GZ	53